Heart Transplantation Clinical Trials

A listing of Heart Transplantation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 101 clinical trials
Expanding the Pool in Orthotopic Heart Transplantation

+) donors to HCV seronegative recipients on the heart transplant waitlist. Treatment and prophylaxis will be administered, using a transmission-triggered approach for the first scenario (HCV Ab+/NAT- donors

sofosbuvir
drug use
hepatitis b surface antigen
hepatitis b
organ transplantation
  • 23 views
  • 27 Jan, 2021
  • 1 location
Belatacept in De Novo Heart Transplantation

The purpose of this study is to determine if Belatacept is safe to give to adult heart transplant recipients. Belatacept (NULOJIX) is an anti-rejection medication that is available through a

heart transplant
influenza
nulojix
drug trials
hepatitis b
  • 20 views
  • 26 Jan, 2021
Impact of Evolocumab in Cardiac Transplant Patients With CAV

received a heart transplant. This drug works as a PCSK9-inhibitor. The primary objective of this study is to measure the impact of PCSK9-inhibitors on serum LDL in heart transplant patients with CAV after

vasculopathy
  • 23 views
  • 27 Jan, 2021
  • 1 location
Heart EXPAND Continued Access Protocol

The OCS Heart System will be used to preserve and assess donor hearts that do not meet current standard donor heart acceptance criteria for transplantation in this continued access protocol.

diabetes
carbon monoxide
carbon monoxide poisoning
  • 29 views
  • 28 Jan, 2021
  • 10 locations
Coronary Artery Disease After Heart Transplantation

This study evaluates coronary artery disease after heart transplantation and its relation to platelet function. Furthermore, we will evaluate extracorporeal photopheresis as treatment of

  • 9 views
  • 23 Jan, 2021
  • 1 location
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children

have initiated a phase I/II clinical trial to test the safety and efficacy of the adoptive transfer of autologous thyTreg to prevent rejection in heart transplant children. Condition or disease

heart transplant
immunosuppressants
heart transplantation
  • 0 views
  • 21 Jun, 2021
  • 1 location
Myfortic in Heart Transplant Patients With Gastrointestinal (GI) Symptoms

Stable heart transplant patients on Mycophenolate Mofetil (MMF) will sign a screening consent form in order to be evaluated with the gastrointestinal symptom rating scale (GSRS

  • 3 views
  • 07 Nov, 2020
  • 1 location
Heart Transplantation Using Normothermic Regional Perfusion Donation After Circulatory Death

Normothermic regional perfusion (NRP) utilizes Extracorporeal Membrane Oxygenation (ECMO) or cardiopulmonary bypass to reperfuse the heart and other organs in situ after isolation and ligation of the cerebral vessels. In situ resuscitation of the heart has the added advantage of allowing full hemodynamic and echocardiographic assessment of the donor heart …

ischemia
heart transplantation
  • 2 views
  • 03 Feb, 2021
  • 1 location
Safety and Effectiveness of NRP for DCD Heart Transplantation

This is a prospective, observational, pilot trial to evaluate the feasibility of heart transplantation using normothermic regional perfusion (NRP) donation after donor circulatory death (DCD

  • 0 views
  • 08 Sep, 2021
  • 1 location
Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation

The a series of clinical studies of [18F]FSPG PET/CT showed that [18F]FSPG is safe and promising PET tracer for detecting inflammation with favorable biodistribution and pharmacokinetics in patients. By using [18F]FSPG, which targets system xC, a key player in the active phase of inflammation, the goal of this phase 2 …

  • 0 views
  • 27 Jan, 2021
  • 1 location